98 related articles for article (PubMed ID: 2506386)
1. [Clinical studies of subcapsular orchiectomy with an intracapsular testicular prosthesis--improving the quality of life in patients with prostatic cancer].
Sakamoto M; Ikeuchi T; Kai Y
Gan No Rinsho; 1989 Sep; 35(10):1143-8. PubMed ID: 2506386
[TBL] [Abstract][Full Text] [Related]
2. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
Zhang XZ; Donovan MP; Williams BT; Mohler JL
Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
[TBL] [Abstract][Full Text] [Related]
3. Subcapsular versus total orchiectomy in the treatment of advanced prostate cancer: a randomized trial.
Roosen JU; Klarskov OP; Mogensen P
Scand J Urol Nephrol; 2005; 39(6):464-7. PubMed ID: 16303721
[TBL] [Abstract][Full Text] [Related]
4. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
5. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
6. Subcapsular orchiectomy with intracapsular testicular prosthesis for metastatic prostate carcinoma.
Short KL; Howerton LW; Holt H; Amin M
Urology; 1984 Jul; 24(1):38-40. PubMed ID: 6740847
[TBL] [Abstract][Full Text] [Related]
7. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Rørth M; Giwercman A
J Urol; 1999 Mar; 161(3):822-6. PubMed ID: 10022693
[TBL] [Abstract][Full Text] [Related]
8. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
9. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M
Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
[TBL] [Abstract][Full Text] [Related]
10. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
11. [Subcapsular orchiectomy using the ultrasonic surgical aspirator in patients with advanced prostatic cancer].
Yasumoto R; Minami H; Yoshihara H; Maekawa T; Ameno Y; Hayashi S; Nishisaka N; Kishimoto T
Hinyokika Kiyo; 1992 Dec; 38(12):1379-81. PubMed ID: 1288226
[TBL] [Abstract][Full Text] [Related]
12. Subcapsular orchidectomy in the management of prostatic carcinoma in Nigerians.
Magoha GA
East Afr Med J; 1989 Jun; 66(6):400-3. PubMed ID: 2791945
[TBL] [Abstract][Full Text] [Related]
13. Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion.
Arap MA; Vicentini FC; Cocuzza M; Hallak J; Athayde K; Lucon AM; Arap S; Srougi M
J Androl; 2007; 28(4):528-32. PubMed ID: 17287456
[TBL] [Abstract][Full Text] [Related]
14. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
Pathak AS; Pacificar JS; Shapiro CE; Williams SG
J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostate cancer is associated with low serum testosterone levels.
Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M
Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729
[TBL] [Abstract][Full Text] [Related]
16. Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.
Issa MM; Lendvay TS; Bouet R; Young MR; Petros JA; Marshall FF
J Urol; 2005 Sep; 174(3):893-7. PubMed ID: 16093982
[TBL] [Abstract][Full Text] [Related]
17. [Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma].
Maleeva A; Tsvetkov M; Kekhaĭova M
Vutr Boles; 1980; 19(3):42-6. PubMed ID: 6771918
[TBL] [Abstract][Full Text] [Related]
18. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels.
Boccon-Gibod L; Laudat MH; Guiban D; Steg A
Eur Urol; 1988; 15(1-2):99-102. PubMed ID: 3215246
[TBL] [Abstract][Full Text] [Related]
19. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
20. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
